🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Goldman Sachs Group Inc (GS)

TradeGate
Currency in EUR
561.10
+3.40(+0.61%)
Delayed Data

GS Comments

Now is the perfect time to short GS.
I totally agree.
ProKidney (NASDAQ: PROK) sees a significant surge from $2 to nearly $14 potential. - The company is advancing its chronic kidney disease (CKD) treatment with two Phase 3 trials back on track. - Strong Financials: ProKidney holds $431.5 million in cash, close to its $500 million market cap. - Upgraded Forecasts: BofA Securities has increased its sales predictions for ProKidney's lead therapy, REACT, with peak sales expected to reach $1.8 billion. - Insider Confidence: Billionaire Pablo Legorreta, founder of Royalty Pharma, recently invested €57M in the company. - Speculation is growing that PROK could rise back to $14 or even higher by the end of the year.
Why you are telling us ?
WnerrHeidric On t£ale gre Hello friends have you notice since gold and gas is going down and xau/usd is going up you can make a huge profits from xau/usd.
heck yeah I want to help I'm for them and secses
https://air.tl/JmizmPMO
Tyra banks
price target 🎯 between 400-450$
Heidi Klum
Biggest bank 🏦
Will he go up ?
Really bad
5% gap up after earnings...
Did you mean 15% down?
Buy now
Way over leveraged. Sell while you can..
sell
froud report
300
Here we go, massive scamming.
bad results but up to 400
Good or bad only buy
buy backs and stock rise
400
So…? Earnings what?
it will follow Charles Schwab profits direction and the 12% up today
400
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.